Metastatic Urothelial Cell Cancer
1 clinical trials · Condition
◉ Watch Metastatic Urothelial Cell Cancer
| Record | Firm | Date |
|---|---|---|
| A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients (NCT03502681) | Monika Joshi, MD | 2018-06-12 |
Track Metastatic Urothelial Cell Cancer automatically
Every clearance here is in the API, with alerts when new ones post.